Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.

about

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.

Item

http://www.wikidata.org/entity/Q36988748

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Estimated Glomerular Filtratio ...... soproxil Fumarate or Abacavir.

@en

type

Item

label

Estimated Glomerular Filtratio ...... soproxil Fumarate or Abacavir.

@en

prefLabel

Estimated Glomerular Filtratio ...... soproxil Fumarate or Abacavir.

@en

P1476

Estimated Glomerular Filtratio ...... soproxil Fumarate or Abacavir.

@en

P2093

Alessia Carbone

http://www.w3.org/2001/XMLSchema#string

Andrea Poli

http://www.w3.org/2001/XMLSchema#string

Laura Galli

http://www.w3.org/2001/XMLSchema#string

Marco Ripa

http://www.w3.org/2001/XMLSchema#string

Nicola Gianotti

http://www.w3.org/2001/XMLSchema#string

Stefania Salpietro

http://www.w3.org/2001/XMLSchema#string

P2860

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

P304

e3780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000003780

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27258510

http://www.w3.org/2001/XMLSchema#string

P932

4900718

http://www.w3.org/2001/XMLSchema#string